Sort
10,829 grants matching “car t”
CAREER: Towards Provenance-Driven Understanding of Machine Learning Robustness
$490,025Birhanu Eshete · Regents Of The University Of Michigan - Dearborn · · FY2023 · CSE
CAREER: Modeling Situated Intention during Nondeterministic Pedestrian-Vehicle Interactions through Explainable Compositional Learning of Naturalistic Driving Data
$490,012Renran Tian · Indiana University · · FY2022 · CSE
Individual Differences in the Development of Spatial Skills: Role of Hippocampal Function and Structure
$489,969Shannon M. Pruden · Florida International University · R01 · FY2020 · HD
SHF: Small: INCA: Incremental Analysis of Software Specification for Evolving Systems
$489,946Allison Sullivan · University Of Texas At Arlington · · FY2022 · CSE
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
$489,764Loning None Fu · Baylor College Of Medicine · R01 · FY2020 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,534Brian Till · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$489,533Brian Till · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Flow Cytometric Evaluation of Biomarkers
$489,372Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
CD19 Directed CAR Therapy
$489,347Carl H. June · University Of Pennsylvania · R01 · FY2014 · CA
Viral Production Core Facility
$489,219Jeffrey C Smith · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$489,159Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$489,159Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Correlative Science
$489,142David B. Miklos · Stanford University · P01 · FY2025 · CA
Engineering Fuel Cell Electrodes to Overcome Ion Transport Limitations using Low-cost, Efficient Lignin-based Ionomers
$489,134Shudipto K Dishari · University Of Nebraska-Lincoln · · FY2023 · ENG
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$489,115Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Using Interactive Virtual Presence to Remotely Assist Parents with Child Restraint Installations
$489,017David C Schwebel · University Of Alabama At Birmingham · R01 · FY2021 · HD
Engineering T-cells with optimized anti-HIV chimeric antigen receptors and CCR5 disruption as a strategy to target HIV-infected cells
$488,955Thor Andrew Wagner · Seattle Children'S Hospital · R01 · FY2017 · AI
Equal Channel Angular Extrusion (ECAE) Processing of Tau-MnAl Magnets
$488,926Ian Baker · Dartmouth College · · FY2019 · ENG
Electrokinetic paper diagnostic platform: 15-minute, quantitative nucleic acid amplification for viral pathogens in whole blood
$488,906Jonathan D Posner · University Of Washington · R01 · FY2017 · EB
The Role of Sensory Predictions in Updating Perception and Action
$488,904Amanda S Therrien · Thomas Jefferson University · · FY2025 · SBE
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection
$488,643Todd M Allen · Massachusetts General Hospital · R37 · FY2022 · AI
Tailored Web Program to Reduce At-Risk College Drinking
$488,563C. Raymond Bingham · University Of Michigan At Ann Arbor · R01 · FY2007 · AA
GOALI: Development of Next Generation MXene-based Li-S Batteries with Practical Operating Temperatures
$488,522Vibha Kalra · Drexel University · · FY2022 · ENG
GENETICALLY ENGINEERED T CELLS FOR DIPG
$488,517Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2024 · NS
NSF/BIO-DFG: Tuning Microtubule-Actin crosstalk to control Mitotic Fidelity
$488,281Linda G Wordeman · University Of Washington · · FY2023 · BIO